The exemplary arrangements relate to ammonium salts of partially fluorinated organic acids. The exemplary arrangements also relate to methods of synthesis of the ammonium salts of partially fluorinated organic acids. The exemplary arrangements also relate to methods of use of the ammonium salts of partially fluorinated organic acids to produce stabilizing emulsions of the oil-in-water and/or water-in-oil type. The exemplary arrangements also relate to methods of use and applications of the ammonium salts of partially fluorinated organic acids, for example use as stabilizing agents in blood substitute preparations.

The present invention relates to the technical field of medicine, and to derivatives represented by formula 1 and formula 2 in which a carboxylic acid group is introduced into the structure of Ginkgolide B by means of a hydroxyl group at the 10-position and ester derivatives of carboxylic acid groups, and pharmaceutically acceptable organic or inorganic salts. Ginkgolide B is used as a parent body and is prepared by means of chemical structure modification so as to achieve the goals of improving solubility, increasing bioavailability and enhancing healing efficacy. The prepared compound and carboxylate salts thereof have significant platelet activating factor antagonism, an anticoagulant effect and an anti-acute cerebral ischemia effect, and can be used for preparing a drug for preventing and treating ischemic stroke, thrombosis, angina pectoris, cardiopulmonary infarction, as well as inflammation, asthma and other diseases related to a platelet activating factor.

##STR00001##

The present invention relates to a thermo-responsive solution and in particular, a solution for use in an osmosis process that is suitable for separating or purifying solutes and or water from an aqueous solution on a large scale and under energy efficient conditions.

The present invention relates to a thermo-responsive solution and in particular, a solution for use in an osmosis process that is suitable for separating or purifying solutes and or water from an aqueous solution on a large scale and under energy efficient conditions.

Described is a method of selectively isolating non-rigid structure meroterpenes (for example, cannabidiolic acid) from a complex matrix that may also contain rigid structure meroterpenes (for example, THCa), comprising selectively precipitating the non-rigid structure meroterpenes in the form of a triethylamine salt complex by adding triethylamine; isolating the triethylamine salt complex from the mother liquor; then heating the triethylamine salt complex to vaporize the triethylamine, leaving an isolated neutral non-rigid structure meroterpene. In certain embodiments, the starting product is a cannabis resin that has been solubilized in, for example, d-limonene.

A compound according to an embodiment is represented by Formula 1. An electrolyte includes a lithium salt, an organic solvent, and the compound. A lithium secondary battery includes a cathode, an anode disposed to face the cathode, a separation membrane interposed between the cathode and the anode, and the electrolyte. In a method for preparing the compound, a compound represented by Formula 2 and a compound represented by Formula 3 are reacted.

The present invention relates to a thermo-responsive solution and in particular, a solution for use in an osmosis process that is suitable for separating or purifying solutes and or water from an aqueous solution on a large scale and under energy efficient conditions.

The present invention relates to a thermo-responsive solution and in particular, a solution for use in an osmosis process that is suitable for separating or purifying solutes and or water from an aqueous solution on a large scale and under energy efficient conditions.

The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.

The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.